Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001204781 | SCV001376002 | uncertain significance | Early myoclonic encephalopathy | 2022-09-01 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with JMJD1C-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 936058). This variant is present in population databases (rs200952020, gnomAD 0.03%). This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 1084 of the JMJD1C protein (p.Val1084Met). |
Ambry Genetics | RCV004033628 | SCV004889522 | uncertain significance | not specified | 2023-10-10 | criteria provided, single submitter | clinical testing | The c.3250G>A (p.V1084M) alteration is located in exon 10 (coding exon 10) of the JMJD1C gene. This alteration results from a G to A substitution at nucleotide position 3250, causing the valine (V) at amino acid position 1084 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |